The stock market's obsession engine: AI fever, tariff jujitsu, and a Dollar trap in waiting

When it comes to stock picking, single-stock traders have fixed their attention on one obsession: generative AI. And it’s not just drawing attention—it’s dominating the entire story. A 25% probability boost story is capturing all investor focus. Everything else is just background noise.

The Goldman Sachs GenAI basket is on a moon mission—RSI north of 70 for weeks, valuations stretched, narratives on fire. All the former bear ammo—capex digestion, Chinese chip water rationing, diffusion fatigue, supply chain bottlenecks—have been neutralized, mocked, or swept aside. The market’s not just chasing GenAI—it’s treating it like the new benchmark, rotating capital into anything with narrative momentum and earnings elasticity. Secular cyclicals with story arcs and high-beta heart rates are the new safe haven. Euphoric? Yes. And starting to smell a bit like June 2024’s blowoff top—with call options replacing logic.

The cloud complex is stirring. Oracle’s capacity warnings, AWS and Azure’s infra expansion into H2—suddenly the “cloud cliff” is being recast as a launchpad. MongoDB, Snowflake, Datadog—they’re all catching flows again. Amazon’s growth, steady at 17% year-on-year, has become a battleground—bulls see upside surprise on GenAI tailwinds, bears say margins are maxed, and hyperscalers are outgrowing them. This isn’t about revenues anymore—it’s about who gets the lion’s share of AI’s next S-curve.

Underneath, the stealth rally is forming in real-time production data. The Census Bureau says 9% of firms already use AI tools in production. That number is rising faster than Nvidia’s guidance. That’s your hidden productivity lever. AI is starting to offset tariff drag, operating like an invisible economic stimulus package with a silicon backbone.

Meanwhile, the tariff narrative is morphing. Since April 5th, markets have priced them like an economic tumour—discounting earnings, bracing for inflation's impact, and hoping for remission. But what if this wasn’t pathology? What if Trump’s tariffs were engineered, not improvised—less political showmanship, more economic reset? Picture the poker table: everyone thinking he’s bluffing, and he flips over a full house—30% on China, 10% for the rest, and a one-year extension to adjust or fold. That’s not chaos. That’s calculated leverage.

Rumour has it he’s about to hold a masterclass in time arbitrage via one-year extensions. Offering a 12-month grace period reduces uncertainty while locking in higher tariffs. Businesses gain clarity. Hiring resumes. Capital expenditures return. It’s like freezing the battlefield before reshaping it. Volatility subsides, and risk premiums tighten. And all of it comes with a built-in fiscal sidecar: $400 billion annually redirected straight into U.S. tax revenue. That’s fiscal tightening without legislative pain—a stealth deficit reduction plan disguised as protectionism.

Here’s the kicker: global partners will grumble, but they’ll take 10% tariffs with an offramp over rolling uncertainty or 20% hikes. And if they liberalize markets under pressure, Trump chalks up a win—no new deals, no tape bombs, just pressure and patience. Call it trade jujitsu: using your opponent’s defensive instincts against them. And once the market digests that this isn’t a tantrum, but the blueprint of a new regime, the short dollar trade isn’t just in trouble—it’s gasoline-soaked. One spark, and it’s going up in flames.